Introduction
Pylephlebitis, defined as septic thrombophlebitis of the portal vein system, is usually secondary to a suppurative process developed in the region drained by the portal vein (troncular phylephlebitis) or by its main tributaries (mesenteric or splenic phylephlebitis) [1] . Pylephlebitis was diagnosed at autopsy and described for the first time by Waller in 1846 in a patient affected with appendicitis [2] . In the past its prognosis was extremely poor, but broad-spectrum antibiotics and surgical removal of the infective focus were able to decrease both its incidence and mortality.
Pylephlebitis was described as a Crohn's disease complication in 1946 by Taylor [3] and, to the best of our knowledge, only other 8 cases have been reported so far [2, [4] [5] [6] [7] [8] . Furthermore, only in three of them the superior mesenteric vein was described to be primarily involved. We report a case of septic shock due to mesenteric pylephlebitis in a patient affected with recently diagnosed ileal Crohn's disease. This work has been reported in line with the SCARE criteria [9] .
Presentation of case
A 47-year-old man was admitted to the emergency department because of a septic shock. He had been complained from 3 h of a peri-umbilical abdominal pain associated to fever and shivering. These symptoms were quickly followed by a severe hypotension. His medical history included histologically confirmed ileal Crohn's disease diagnosed 4 years before and treated with mesalamine only. He was 187 cm tall and 92 kg weight. Physical examination revealed a fixed peri-umbilical mass without abdominal guard- ing. Blumberg sign was negative. Initial workup revealed severe leukopenia (300 white blood cells/mcL) and high procalcitonin levels (453 g/L). Abdominal x-ray excluded an intestinal perforation. Abdominal computed tomography (CT) scan was performed ( Fig. 1) : it confirmed the presence of a Crohn's disease involving the terminal ileum for a length of about 70 cm. Along this small bowel tract the mesentery was extremely inflamed as in a phlegmonous condition causing the obstruction of the inferior mesenteric vein. Air bubbles were visible both in the mesentery and in the liver. These findings were suggestive for mesenteric pylephlebitis complicating ileal Crohn's disease. The patient was in a severe septic shock but without having clinical sign of abdominal perforation and peritonitis. Both leukopenia and high procalcitonin value suggested the presence of Gram-negative bacteremia. Patient was promptly supported by mechanical ventilation and vasopressors agents. A broad-spectrum antibiotic therapy (intravenous carbapenem: meropenem 1 gr per 3 times/day) was administered and the catabolic state corrected with both enteral and parenteral nutritions. Peripheral blood culture showed the presence of Klebsiella oxytoca and Escherichia coli. Antibiotics and fluids resuscitation brought the patient to a quick improvement of his general conditions and after 3 weeks in the intensive care unit the patient was discharged. He underwent elective surgery about two months later. At surgery the mesenterium of the terminal ileum was extremely retract and increased in its thickness (more than 8 cm), with some diseased ileal loops tangentially attached to it. An ileo-colic resection (80 cm + 7 cm) was performed, followed by an ileo-colic side to side anastomosis. Post-operative course was uneventful and the patients discharged at day 10. Histology confirmed Crohn'disease of the terminal ileum associated to an obliterative vasculopathy (Fig. 2) . Biological therapy was started and after 6 months follow-up the patient is in good general conditions and free from recurrence.
Discussion
Mesenteric pylephlebitis is an infective suppurative thrombosis of the mesenteric vein or its branches. It is usually secondary to the development of intra-abdominal infective foci typically complicating diverticular disease, appendicitis and necrotizing pancreatitis [2] . This critical clinical condition can arise in inflammatory bowel diseases too [2] [3] [4] [5] [6] [7] [8] . However, in Crohn's disease it is extremely rare. Furthermore, as showed by this report, the occurrence of such a complication seems not to be directly related to the severity of the Crohn's diseased: our patient was affected by a mild form of Crohn's disease, recently diagnosed and treated with mesalamine only.
The patient experienced septic shock without clinical signs of peritonitis: we believe in Crohn's disease it is extremely important mesenteric pylephlebitis to be considered in presence of such clinical presentation, since nowadays, as showed by this report, through a resuscitation therapy associated to broad-spectrum antibiotics and enteral and parenteral nutrition, it is a curable condition even in presence of concomitant Crohn's disease. Two months after the patient had been discharged from the intensive care unit, we indicated surgery, performing the ileo-colic resection with ileo-colic side to side anastomosis. We believe the strict clinical evaluation by surgeons, gastroenterologists and anesthesiologists was extremely important allowing the patient to be electively operated in a "window" period characterized by a good global health status, starting from an obtimal nutritional repletion, auspicable expecially in patients affected with Crohn's disease, to obtain an uneventful postoperative outcome, as well as to minimize the risk of post-operative stoma [10] . Interestingly, histological analysis on the surgical specimen confirmed the presence of an obliterative vasculopathy, even in absence of the initial clinical symptoms.
Conclusion
Multidisciplinary approach is mandatory for the decision making process in presence of mesenteric pylephlebitis, to obtain both a correct diagnosis and a prompt treatment. In fact, although surgical approach is often necessary, timing for surgery is very important in order to operate the patient in an elective setting, which is mandatory to perform a bowel sparing surgery, minimizing the intra and post-operative complications.
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